Publication Generation and selection of pluripotent stem cells for robust differentiation to insulin-secreting cells capable of reversing diabetes in rodents. admin September 5, 2018
Press Release Seraxis Inc. announces novel method and cell line that generate highly pure populations of insulin-producing cells capable of reversing diabetes in rodents. admin September 5, 2018
Press Release Seraxis Inc. announces a commercialization grant award from the Maryland Stem Cell Research Fund (MSCRF). admin May 11, 2017
Press Release Seraxis Inc. closed a Series B financing Round and enters into a collaboration with Medytox Inc. admin August 10, 2016
